Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
EDITOR,--Anticoagulant prophylaxis may reduce the incidence of venous thromboembolism in hospital, but C J Todd and colleagues' study does not dispel doubts about its overall effect on mortality.1 There was no significant difference between the survival rate at 90 days (82.2% at the four hospitals that routinely gave such prophylaxis (to 79.5% of patients)) and 82.0% at the other four hospitals (prophylaxis given to only 16.1%) despite the fact that 62.3% of patients in the former hospitals had surgery within 24 hours (favourable to outcome) compared with only 50% in the latter (P<0.01,
2 test). Hospital 4, which gave prophylaxis to the highest proportion of patients (91%), showed joint lowest 90 day survival (76%). In hospitals 5 and 8, in which only 10.5% of patients were given prophylaxis, 83% survived despite 4% dying of pulmonary embolism. None of the 13 patients diagnosed
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?